Legend Biotech Total Assets 2019-2021 | LEGN
Legend Biotech total assets from 2019 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Legend Biotech total assets for the quarter ending December 31, 2021 were $1.118B, a 55.11% increase year-over-year.
- Legend Biotech total assets for 2021 were $1.118B, a 55.11% increase from 2020.
- Legend Biotech total assets for 2020 were $0.721B, a 150.6% increase from 2019.
- Legend Biotech total assets for 2019 were $0.288B, a 32.94% decline from 2018.
Legend Biotech Annual Total Assets
(Millions of US $) |
| 2021 |
$1,118 |
| 2020 |
$721 |
| 2019 |
$288 |
| 2018 |
$429 |
Legend Biotech Quarterly Total Assets
(Millions of US $) |
| 2021-12-31 |
$1,118 |
| 2021-09-30 |
$814 |
| 2021-06-30 |
$875 |
| 2021-03-31 |
$615 |
| 2020-12-31 |
$721 |
| 2020-09-30 |
$709 |
| 2020-06-30 |
$773 |
| 2020-03-31 |
$365 |
| 2019-12-31 |
$288 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$429 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$6.404B |
$0.090B |
|
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
|
